2011
DOI: 10.1517/17460441.2011.570750
|View full text |Cite
|
Sign up to set email alerts
|

Green tea polyphenols in drug discovery: a success or failure?

Abstract: Green tea is made from unfermented dried leaves from Camellia sinensis and has been consumed by humans for thousands of years. For nearly as long, it has been used as a folk remedy for a wide array of diseases. More recently, a large number of in-vitro and in-vivo scientific studies have supported this ancient contention that the polyphenols from green tea can provide a number of health benefits. Since these compounds are clearly safe for human consumption and ubiquitous in the food supply, they are highly att… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 38 publications
1
22
0
Order By: Relevance
“…We are now exploring these possible mechanisms. EGCG, like other green tea polyphenols, is relatively unstable, poorly absorbed, and undergoes metabolic alterations (69). The serum concentration obtained after oral ingestion of pure EGCG (2 mg/kg in 100 ml of water, which is approximately the equivalent of two cups of green tea) was 0.17 M (70), below the antiviral EC 50 .…”
Section: Discussionmentioning
confidence: 96%
“…We are now exploring these possible mechanisms. EGCG, like other green tea polyphenols, is relatively unstable, poorly absorbed, and undergoes metabolic alterations (69). The serum concentration obtained after oral ingestion of pure EGCG (2 mg/kg in 100 ml of water, which is approximately the equivalent of two cups of green tea) was 0.17 M (70), below the antiviral EC 50 .…”
Section: Discussionmentioning
confidence: 96%
“…Although EGCG is a natural product with extremely low toxicity issues, it has several problems if it is to be used as a therapeutic agent (49). It is poorly absorbed in the intestinal tract, it is rapidly modified by enzymes such as catechol-O-methyltransferease, and its anti-oxidant activity makes it relatively unstable in solution.…”
Section: Discussionmentioning
confidence: 99%
“…Further, another study [19] has also mentioned that OSU-03012 treatment reduced GRP78 expression in GBM cells and that there is likelihood that OSU-03012 destabilizes GRP78 by binding to it. Like EGCG [20], OSU-03012 readily crosses the blood-brain barrier [19].…”
Section: Inhibitors Against Grp78mentioning
confidence: 99%